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Cardiometabolic risk factors, metabolic 
syndrome and pre-diabetes in adolescents 
in the Sierra region of Ecuador
Sharon L. Casapulla1,2,4,7*, Cheryl A. Howe3,4, Gabriela Rosero Mora10, Darlene Berryman3,4,5, Mario J. Grijalva4,5,7, 
Edgar W. Rojas6,8, Masato Nakazawa5 and Jay H. Shubrook4,9
Abstract 
Background: Excess weight (overweight and obesity) is the major modifiable risk factor for type 2 diabetes mellitus 
(T2DM) and other non-communicable diseases. However, excess weight may not be as predictive of diabetes risk as 
once thought. While excess weight and other obesity-related non-communicable diseases are of growing concern 
in low-middle income countries in Latin America, there is limited research on risk factors associated with T2DM in ado-
lescents. This study investigated prevalence of overweight, obesity, prediabetes, diabetes and metabolic syndrome in 
adolescents in Ecuador.
Methods: A cross-sectional study was conducted with 433 adolescents from two schools in a small urban center 
in southern Ecuador and two schools in a large urban center in Quito. Risk factors were measured, including: height, 
weight, BMI, waist-to-hip ratio, fasting glucose, lipid panel, and HbA1c. Multivariate analysis of variance (MANOVA) 
was separately applied to risk factors and demographic factors as a set of dependent variables with sex, location and 
their interaction included as predictors. An independent t test was run on the data at 95% confidence intervals for the 
mean difference. The values for the triglycerides, LDL and VLDL were positively skewed. A Mann–Whitney U test was 
run on these data.
Results: Using IOTF standards, 9.8% were overweight and 1.9% were obese. Only 1.6% of the sample met the criteria 
for prediabetes by fasting glucose but 12.4% of the sample met the criteria for prediabetes by HbA1c. None of the 
participants met criteria for diabetes. There were 2.3% of the participants that met the IDF criteria for metabolic 
syndrome. Adolescents from the larger urban center had higher rates of prediabetes, higher mean HbA1c, blood pres-
sure, lipid values, and lower HDL levels.
Conclusions: Use of HbA1c identified more adolescents with prediabetes than FBG. The HbA1c measure is an 
attractive screening tool for prediabetes in developing countries. Although rates of obesity in Ecuadorian adolescents 
are low there is significant evidence to suggest that prediabetes is permeating the smaller urban centers. Traditional 
screening tools may underestimate this risk.
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
In Latin America (LA), non-communicable diseases 
(NCDs), including diabetes and cancers, are now among 
the leading causes of mortality [1]. For example, rates of 
diabetes in LA are predicted to increase by more than 
59%, with 39.9 million predicted to have diabetes by 2030 
[2–4]. Excess body weight (overweight and obesity) has 
been considered the key modifiable risk factor for type 2 
diabetes mellitus (T2DM) and represents a major public 
health concern both in terms of individual quality of life 
and cost to health care systems in LA [1, 5]. Relatively 
recent data (2010) suggest that about half of the adults in 
LA are overweight or obese, up from 33.9% a decade ear-
lier [6]. Adolescents in LA are not immune to this trend. 
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In fact, the World Health Organization (WHO) is calling 
childhood obesity “one of the most serious public health 
challenges of the twenty first century [1]”. Countries 
undergoing rapid demographic and dietary shifts due to 
an evolving economic climate, such as many countries 
in Latin America, are among the most vulnerable [1, 6]. 
A study in adolescent girls in low middle income coun-
tries (LMICs) found that LA and the Caribbean had the 
highest regional prevalence of overweight in both rural 
and urban areas [7]. Further, it was recently found that 
the worldwide prevalence of diabetes may be significantly 
underreported. The International Diabetes Federation 
previously estimated that 420 million people have diabe-
tes worldwide but it is believed that it is closer to 520 mil-
lion people [8].
Ecuador is experiencing rapid socioeconomic and 
demographic transition [9]. Few studies have investigated 
how these changes have affected the adolescent popula-
tion in Ecuador in terms of body weight, comorbidities, 
and cardiometabolic risk factors. Census data indicate 
that the prevalence of overweight in adolescents (aged 
12–19) is 18.8%, obese 7.1%, overweight and obese (com-
bined) is 26% [10] and that prevalence rates of overweight 
and obesity in adolescents vary by region [10]. The urban 
Sierra (22.4%), rural Sierra (16.8%) and the rural coastal 
(15.2%) regions have the highest prevalence of over-
weight in adolescents. The highest prevalence of adoles-
cent obesity is found in the Galapagos Islands province 
(13.8%). Rural areas in the costal and Sierra regions had 
the lowest rates of adolescent obesity (4.2%). Quito, the 
capital, has prevalence rates of overweight and obese 
adolescents of 18.8 and 5.5%, respectively [10].
Yepez et al. [11] estimates that the prevalence of over-
weight and obesity were 13.7 and 7.5%, respectively, in 
a group of Ecuadorian adolescents. Ochoa-Aviles et  al. 
[12] reports overweight and obesity rates to be 18.0 and 
2.1%, respectively. Adolescents from rural areas were 2 to 
4-times more likely to present with higher levels of cho-
lesterol, triglycerides, and lower levels of HDL than those 
from the urban areas. Collectively, these studies demon-
strate the need for further investigation into the health of 
Ecuadorian adolescents [12].
The current study was designed to expand on the pre-
vious research to identify and more fully understand the 
presence of overweight and obesity rates, cardiometa-
bolic risk factors, prevalence of type 2 diabetes, prediabe-
tes and metabolic syndrome in Ecuadorian adolescents. 
Cariamanga, a small urban center in the southern Loja 
province, and Pomasqui, a larger urban area within the 
Quito Metropolitan District are the two areas included 
in the study. We hypothesized that adolescents from the 
smaller urban center of Cariamanga would have lower 
rates of obesity, metabolic syndrome and diabetes, and 
fewer cardiometabolic risk factors than adolescents living 
in the larger urban center of Pomasqui.
Methods
Study area
A cross-sectional study was conducted from March to 
July 2015 in two urban centers in the Sierra region of 
Ecuador. A total of four schools were used in this study, 
two from larger and two from smaller urban regions. Par-
ticipants were recruited from two high schools located in 
Pomasqui, a densely populated urban Parrish belonging 
to the Quito Metropolitan District in the northern part 
of the country. Pomasqui (population 28,910) is located 
along a major highway that connects Quito, the country’s 
capital (population 1.6 million), with the Coastal region. 
Agricultural activities are limited due to dry climate. 
Most of the population works within the Metropolitan 
district in commerce, manufacturing and service jobs. 
They are, for the most part, low to low-middle income.
Participants were also recruited from two high schools 
in the smaller urban center of Cariamanga (population 
13,311) located in Calvas County in the southern Sierra 
Loja Province. Most economic activity among permanent 
residents involves commerce and service jobs. Because 
it is the only urban center in the mostly rural Calvas 
County, part of the population is involved in agricultural 
production and the schools attract a transient adolescent 
population from nearby rural villages. The population is 
largely of low to low-middle income status.
Sampling
Adolescents ages 13–18 (N =  433) were recruited from 
two schools in Pomasqui, (n =  219) and two schools in 
Cariamanga (n = 214). As this was a community- based 
study and the participants were limited to older adoles-
cents, the participants were not subjected to Tanner stag-
ing (See Fig. 1).
Ethics
The investigative team obtained approval from the local 
school rectors, the Ministry of Education and the Under-
secretary of Education to conduct this study. Adolescents 
were excluded from the study if they had any physical, 
physiological, or other health issues (including preg-
nancy) that would preclude them from participation. A 
research physician was on site to evaluate any participant 
if it was unclear whether or not they were appropriate for 
the study. Parental consent was obtained from parents/
guardians, and assent was obtained from all adolescents 
under the age of 18 years. Informed consent was obtained 
from all 18-year-old adolescents. All protocols were 
approved by the Institutional Review Boards of Ohio 
University and Pontifical Catholic University of Ecuador.
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Anthropometric measurement
Standard procedures were used for assessing anthropo-
metric measures, including light clothing and no shoes. 
Height was measured to the nearest 0.1 cm using a port-
able stadiometer (Seca 213 Mobile Stadiometer, Sno-
qualmie, WA) and weight to the nearest 0.1  kg using a 
calibrated digital scale (Seca 874 Digital Scale). Height 
and weight were used to calculate BMI (kg/m2). BMI 
percentile was used to determine weight status accord-
ing to age and sex-specific growth charts published by 
the World Health Organization (WHO) [13] and the 
International Obesity Task Force (IOTF) [14]. Abdomi-
nal obesity was assessed using waist-to-hip ratios 
(WHR  =  waist/hip). Waist circumference (cm) was 
measured using a tension-regulated tape measure along 
a horizontal line at the level of the anterior superior iliac 
spine. Hip circumference was measured along a horizon-
tal line at maximum posterior extension of the buttocks. 
All anthropometric measurements were repeated three 
times by a pair of trained interviewers. Averages of the 
repeated measurements were used in all calculations and 
analyses.
Blood pressure measurements
Systolic blood pressure (SBP) and diastolic blood 
pressure (DBP) were measured using a manual 
sphygmomanometer (Welch Allyn DS66, Skaneate-
les Falls, NY) with an appropriate cuff size. Subjects 
were seated with their backs and feet supported for at 
least 5 min before blood pressure was measured. Meas-
urements were repeated two additional times, with a 
1–2  min interval between each reading. SBP and DBP 
measurements were compared to percentile standards 
for age, sex, and height. Measurements above the 95th 
percentile were considered hypertensive [15]. Following 
each BP measurement, resting heart rate (HR) was meas-
ured for the last 15  s of 1  min by a trained investigator 
using the radial pulse. For all measurements, the average 
of three measurements was used in analyses. Metabolic 
syndrome was determined using the International Diabe-
tes Federation (IDF) criteria for children and adolescents, 
grouping those less than age 16 and those age 16 and 
greater [16].
Blood sample analysis
The subjects fasted for at least 8 h prior to participating 
in the study. Following resting blood pressure measure-
ments, a trained phlebotomist drew intravenous blood 
samples on site. Blood samples were collected in vacu-
tainer tubes and immediately spun at 3500  rpm for 
10 min. Samples were stored in the field at 4 °C until they 
were transferred to a local lab for analysis within 5 h of 
collection (Netlab, Quito, Ecuador). Blood samples were 
analyzed in a laboratory using a method that is NGSP 
certified and standardized to the DCCT assay for triglyc-
eride (TG) levels, high density cholesterol (HDL), total 
cholesterol (TC), hemoglobin A1c (HbA1c) and fast-
ing blood glucose (FBG). Very low density lipoprotein 
(VLDL) and low density lipoprotein (LDL) cholesterol 
were calculated.
Blood glucose levels were measured with the enzymatic 
method GOD-PAP [17]. The field research team experi-
enced an equipment error (centrifuge) on one of the test-
ing days in the field. As a result, the FBG readings from 
53 participants from the Cariamanga sample were not 
usable and were excluded from the analyses.
Data analysis
Multivariate analysis of variance (MANOVA) was sepa-
rately applied to risk factors (HbA1c, TC, HDL, TG, LDL 
and VDL) and demographic factors as a set of dependent 
variables (DVs) with sex, location and their interaction 
included as predictors. The MANOVA model was fol-
lowed by a univariate multiple regression model for each 
DV. If MANOVA F-tests were significant, the univariate 
models were tested without any adjustment; otherwise, 
the Holm’s method was applied. Extreme outliers were 
defined as participants who had standardized residu-
als greater than 4.5 in any of the variables. All tests were 
Consented for 
anthropometrics and blood 
lipids
N=460
Dropped 16 due to 
invalid birthdates
N=444
Dropped 53 FBG due to 
equipment malfuncon
FBG n=375
Dropped 16 due to 
Nanegalito sample excluded
N=428
Valid Anthropometrics 
and Blood Lipids  
n=428
Fig. 1 Recruitment of participants, including drop outs at each stage 
and remaining number of participants
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performed 2-tailed at the significance level of 5%. Data 
were analyzed using IBM SPSS version 22 [18] and the R 
statistical language version 3.2 [19].
TC, HDL, BMI, FBG and HbA1C were normally dis-
tributed for sex groups, and there was homogeneity of 
variance as assessed by Levene’s Test for Equality of Vari-
ances. Therefore, an independent t-test was run on the 
data as well as 95% confidence intervals (CI) for the mean 
difference. The values for the TG, LDL and VLDL were 
positively skewed. Therefore, a Mann–Whitney U test 
was run on these data.
Results
A total of 433 adolescents participated in the study 
(Table  1). The number of adolescents in Cariamanga 
(49.4%) was similar to the number of adolescents in 
Pomasqui (50.6%). There were more female (68.1%) 
than male (31.9%) participants in both locations. Table 2 
summarizes descriptive statistics of the overall sample 
as well as by sex and location. The mean age of all ado-
lescents was 15.1 ±  1.6  years with a mean BMI for age 
of 20.7 ± 3.4 kg/m2, and WHR of 0.83 ± 0.1. Using the 
IOTF classification system, 9.8% of the total sample was 
overweight and 1.9% was obese. Table 3 compares results 
of overweight status and obesity using WHO [13] and 
IOTF [14] classification systems.
Of the 428 samples successfully drawn, a total of 375 
adolescents had valid FBG measures. Of these, no ado-
lescents had glucose >126 mg/dL. Six (1.6%) of the ado-
lescents had FBG levels 100–126  mg/dL, indicative 
of prediabetes. A total of 428 adolescents had a valid 
HbA1c. None had an HbA1c ≥6.5% (48 mmol/mol), but 
53 (12.4%) had an HbA1c 5.7–6.4% (39–46  mmol/mol), 
indicative of prediabetes.
Ten (2.3%) adolescents (six girls and four boys) over 
16 years old met the IDF criteria for metabolic syndrome 
in children and adolescents, evenly distributed between the 
two locations. None of the adolescents under 16 met the 
IDF criteria. In addition to waist circumference, low HDL 
was the one risk factor common to all ten adolescents who 
met the IDF for metabolic syndrome. High triglycerides 
were present in five of the ten adolescents with metabolic 
syndrome. Elevated glucose was present in only one of the 
ten. Four (two girls and two boys) of the ten with metabolic 
syndrome also had prediabetes based on HbA1c.
Girls versus boys
As expected, there were some significant differences in 
anthropometric data between boys and girls. Table 3 pre-
sents the percentages of overweight and obese by WHO 
and IOTF classification for both males and females. Girls 
had higher BMI compared to boys (p < 0.001). Boys had 
higher SBP (p  =  0.003) and DBP (p  =  0.05) than girls. 
Girls had higher TC (p  <  0.001), LDL (p  <  0.001), HDL 
(p  =  0.01), VLDL (p  =  0.01) and TG (p  =  0.009) than 
boys. There were no significant sex differences in HbA1c 
(p = 0.32). Of the adolescents 16 and older, 33% (39/119) 
girls had a waist circumference ≥80 cm, and 12% (6/51) 
boys had a waist circumference ≥90 cm.
Location differences
Using the IOTF weight classification system, 9.8% of the 
total sample was overweight, and 1.9% was obese. Total 
overweight and obesity rates combined were 14.5% in 
Cariamanga and 8.9% in Pomasqui based on IOTF cri-
teria. Adolescents from Pomasqui had similar rates of 
obesity (2.8%) to adolescents from Cariamanga (0.9%). 
While there were no significant differences in rate of 
obesity by location, adolescents from the smaller urban 
center of Cariamanga did have higher rates of overweight 
(13.6%) than adolescents from the larger urban center of 
Pomasqui (6.1%), using the IOTF criteria. Adolescents 
from Cariamanga had higher WHRs (0.85 ±  0.04) than 
(0.82  ±  0.06) adolescents from Pomasqui (p  <  0.001). 
There was a higher proportion of overweight adolescents 
in Cariamanga than in Pomasqui (p = 0.018) but no sig-
nificant difference in obese adolescents (p = 0.30).
Adolescents from Pomasqui had higher prevalence of 
prediabetes (HbA1c 5.7–6.5%; 39–46 mmol/mol) (16.8%) 
than adolescents from Cariamanga (1.9%) (p  <  0.001) 
and higher FBG (p  <  0.001) than adolescents Caria-
manga. Adolescents from Pomasqui also had higher TC 
(p < 0.001), LDL (p < 0.001), VLDL (p =  0.02), and TG 
(p  =  0.03). In contrast, HDL was lower in adolescents 
from Cariamanga (p < 0.001). Adolescents from Pomas-
qui had higher SBP (p = 0.03) and DBP (p < 0.001).
Table 1 Frequency distributions by sex and location
Total Male Female
n % n % n %
Total sample 433 138 31.9 295 68.1
Location
 Cariamanga 214 49.4 67 31.3 147 68.7
 Pomasqui 219 50.6 71 32.4 148 67.6
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Sex by location interaction
Both sex and location were significant predictors of 
the six cardiometabolic risk factors (HbA1c, TC, HDL, 
TG, LDL and VLDL) as a set [sex: Wilk’s λ = 0.93, F(6, 
418)  =  5.2, p  <  0.001; location: Wilk’s λ  =  0.87, F(6, 
418) =  10.1, p  <  0.001], while their interaction was not 
(Wilk’s λ =  0.99, F(6, 418) =  0.8, p > 0.05). Specifically, 
sex was associated with all risk factors (ps < 0.05) except 
for HbA1c (p > 0.05) after controlling for location. Loca-
tion was significantly associated with all risk factors 
(ps < 0.05) after controlling for sex. The location by sex 
interaction was not significant for any of the risk factors 
(ps > 0.05).
Table 4 summarizes the results of the regression mod-
els, showing how sex and location influenced the preva-
lence of the cardiometabolic risk factor. All risk factors, 
Table 3 Percent of sample with each weight class and HbA1c range overall and by location
a Applying Chi square test, there is no significant difference
b Applying Chi square test, there is significant difference P = 0.009 WHO Class and P = 0.002 IOTF Class
c Classification using percentiles
Overall Cariamangaa Pomasquia Maleb Femalea
n % n % n % n % n %
WHO weight  classificationc
 Underweight 31 7.3 14 6.5 17 8.0 17 12.5 14 4.8
 Healthy weight 328 76.8 162 75.7 166 77.9 105 77.2 223 76.6
 Overweight 41 9.6 22 10.3 19 8.9 9 6.6 32 11.0
 Obese 27 6.3 16 7.5 11 5.2 5 3.7 22 7.6
IOTF weight classification
 Thinness grade 3 15 3.5 8 3.7 7 3.3 8 5.9 7 2.4
 Thinness grade 2 37 8.7 17 7.9 20 9.4 19 14.0 18 6.2
 Thinness grade 1 69 16.2 33 15.4 36 16.9 27 19.9 42 14.4
 Healthy weight 256 60.0 125 58.4 131 61.5 73 53.7 183 62.9
 Overweight 42 9.8 29 13.6 13 6.1 6 4.4 36 12.4
 Obese 8 1.9 2 0.9 6 2.8 3 2.2 5 1.7
HbA1c status
 HbA1c <5.7 374 87.6 200 174 115 259
 HbA1c 5.7–6.4 53 12.4 12 41 20 33
 HbA1c ≥6.5 0 0 0 0 0 0 0 0 0 0
Table 4 Regression analyses of the cardiometabolic risk factors, anthropometrics and hemodynamics
Data are expressed as β ± standard error
WHR wait-to-hip ratio; BMI body mass index; SBP systolic blood pressure; DBP diastolic blood pressure; HbA1c glycated hemoglobin; TC total cholesterol; TG 
triglyceride; HDL high density lipoprotein; LDL low density lipoprotein; VLDL very low density lipoprotein; FBG fasting blood glucose
* p < 0.05, ** p < 0.01, *** p < 0.001
(Intercept) Sex (male) Location (urban) Sex x location
HbA1c (units) 5.28 ± 0.02*** 0.04 ± 0.04 0.15 ± 0.03*** −0.01 ± 0.05
FBG (mg/dL) 79.17 ± 0.87*** 0.90 ± 1.61 3.85 ± 1.16** 1.49 ± 2.10
TG (mg/dL) 82.17 ± 3.23*** −13.11 ± 5.74* 9.5 ± 4.55* 5.66 ± 8.07
TC (mg/dL) 145.8 ± 2.73*** −25.4 ± 4.86*** 19.72 ± 3.85*** 12.04 ± 6.84
HDL (mg/dL) 47.94 ± 1.16*** −5.27 ± 2.06* 7.82 ± 1.63*** 2.26 ± 2.9
VLDL (mg/dL) 16.46 ± 0.65*** −2.61 ± 1.15* 1.85 ± 0.91* 1.11 ± 1.62
LDL (mg/dL) 81.58 ± 2.09*** −16.52 ± 3.72*** 9.86 ± 2.95*** 7.64 ± 5.23
Waist (cm) 74.22 ± 0.72*** −3.49 ± 1.29** 0.68 ± 1.03 2.47 ± 1.82
Hip (cm) 0.85 ± 0.0*** −0.01 ± 0.01 −0.04 ± 0.01*** 0.03 ± 0.01***
BMI (kg/m2) 21.16 ± 0.28*** −1.68 ± 0.49*** −0.1 ± 0.39 0.51 ± 0.69
SBP (mmHg) 103.44 ± 0.88*** 3.11 ± 1.57* −2.59 ± 1.24* 0.76 ± 2.2
DBP (mmHg) 70.26 ± 0.68*** 2.42 ± 1.22* −3.46 ± 0.97*** −1.15 ± 1.71
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except for HbA1c, were significantly associated with both 
sex and location. Specifically, boys had lower levels of TC, 
HDL, LDL, TG and VLDL than girls regardless of loca-
tion (ps < 0.05). Adolescents from Pomasqui had higher 
values of all risk factors, regardless of sex (ps < 0.05). Sex 
and location did not interact to influence any of the car-
diometabolic risk factors (ps > 0.5).
The multivariate F-test revealed that waist circum-
ference, WHR, BMI, as well as SBP and DBP were sig-
nificantly affected by both sex and location as well as 
their interaction [sex: Wilk’s λ  =  0.95, F(5, 420)  =  4.8, 
p  <  0.001; location: Wilk’s λ  =  0.72, F(5, 420)  =  32.6, 
p  <  0.001; interaction: Wilk’s λ =  0.97, F(5, 420) =  2.9, 
p  =  0.01). Specifically, sex was significantly associated 
with waist, BMI, SBP, and DBP (ps < 0.05) after control-
ling for location, while location alone was associated with 
WHR, SBP, and DBP (ps < 0.05). Sex and location inter-
acted to affect WHR only (p  <  0.001). In Cariamanga, 
boys and girls did not differ in WHR (p > 0.05), while in 
the Pomasqui, boys had higher WHR (p  <  0.001). Con-
versely, girls from Cariamanga had higher WHR than 
girls from Pomasqui (p < 0.001) while boys did not differ 
between locations (p  >  0.05). Regarding the other vari-
ables, waist, BMI, SBP, and DBP were all affected by sex 
(p  <  0.05). Specifically, boys had lower waist and BMI, 
but higher SBP and DBP measures than girls, regard-
less of location. Adolescents from Pomasqui had lower 
SBP and DBP than their counterparts from Cariamanga 
(ps < 0.05) regardless of sex.
Discussion
There were several notable findings from this study. First, 
the prevalence of overweight and obesity in the over-
all sample were lower than anticipated based on previ-
ous research in this region [11, 12]. Second, there were 
relatively low rates of biochemical metabolic abnormali-
ties (dyslipidemia and hyperglycemia) and only 2.3% met 
the IDF criteria for metabolic syndrome. Third, despite 
these factors, almost 10% of the adolescents (n = 43) in 
the sample met the diagnostic criteria for prediabetes. 
Finally, the rate of prediabetes was eight times higher in 
adolescents from the large urban center of Pomasqui as 
compared to the smaller urban center of Cariamanga.
Based on census data and recent studies mentioned 
previously, higher rates of metabolic abnormalities (dys-
lipidemia and hyperglycemia) were expected in the over-
all sample. Only 2.3% of adolescents (n  =  10) met the 
IDF criteria for metabolic syndrome. The higher rates of 
cardiometabolic risk factors in the larger urban center 
of Pomasqui may reflect the availability of a more west-
ernized diet, as has been suggested in previous research 
in LMICs [5]. However, it was surprising that the rates 
of overweight were higher in the smaller urban areas of 
Cariamanga (13.6%) compared to the larger urban center 
of Pomasqui (6.1%). The authors believe that the findings 
demonstrate that the problem of excess weight is spread-
ing to smaller communities in Ecuador and that these 
more rural regions, farther from larger urban centers, are 
also experiencing the early stages of nutrition transition.
Nearly 10% of adolescents in the sample had prediabe-
tes based on an elevated HbA1c and rates were 8× higher 
in the larger urban center of Pomasqui (16.8 vs 1.8%). 
Both the differing rates of prediabetes and the higher 
rates of overweight may indeed confirm that Ecuadorian 
adolescents are in the midst of a nutrition transition [12]. 
These results may indicate that the effects of a western 
lifestyle and diet are permeating more of the country, 
even into the smaller and more remote urban areas in 
southern Ecuador [12]. Of note, the American Diabetes 
Association recommends screening any person above 
the age of 10 who is obese and has at least 2 additional 
risk factors for T2DM. This screening can be completed 
using an A1c [20]. If screenings in this study were limited 
to this standard, a much smaller number of adolescents 
would have been screened and many cases of prediabetes 
would have been missed.
Previous research in the United States showed that the 
HBA1c may be less sensitive than an oral glucose toler-
ance test (OGTT) to diagnose prediabetes and diabetes 
[21]. However, OGTT are often not practical in rural 
and underserved areas. The use of an OGTT has almost 
been completely replaced by the A1c in adults. Because 
of these challenges some authors have suggested that the 
A1c is a necessary tool for the screening of dysglycemia 
in adolescents [22]. A recent study actually showed that 
current A1c cutoffs may underestimate diabetes rates in 
adolescents [23].
The results of this study have important clinical impli-
cations for screening adolescents. Use of HbA1c identi-
fied more adolescents with prediabetes than FBG and 
other metabolic markers. This has also been reported in 
adults [24]. The HbA1c measure is an attractive screen-
ing tool for prediabetes in developing countries for sev-
eral reasons: (1) it does not require the person to fast, (2) 
it is available as a venous or capillary sample, and (3) it is 
enzymatically easier to process than glucose [25]. Clearly, 
if a more traditional biochemical risk factors were used 
in this present study, fewer adolescents would have been 
identified as at risk. Use of HbA1c could be used as a 
screening tool to provide identification earlier on the 
insulin resistance spectrum. The importance of early 
identification in adolescence cannot be understated, as it 
is now known that type 2 diabetes in childhood and ado-
lescence is less responsive to treatment and that adoles-
cents experience beta cell failure faster than others with 
type 2 diabetes [26].
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This study has a number of limitations. While this is 
a representative sample of adolescents in Quito and the 
southern Sierra region of Ecuador, it does not represent 
the diversity of adolescents in the country. Geographic 
differences such as elevation could be confounding vari-
ables affecting some of our results. The study team did 
not do Tanner staging on the participants which lim-
its the confidence that we only included mature adoles-
cents. Further, we did not assess participants for anemia 
and cannot rule out that some of the participants had a 
hemoglobinopathy. However, this would have resulted 
in an under-estimation of diabetes rates. In this study 
socioeconomic data were not collected, and as sug-
gested by previous research [12, 27, 28], socioeconomic 
factors could also be influencing our results. Finally, this 
study measures a single point in time, and cannot pre-
dict the trajectory of these adolescents based on this 
measurement alone. In light of the higher rates of over-
weight in the adolescents from the smaller urban center, 
longitudinal follow up would be illustrative. The use of 
HbA1c is also somewhat controversial. The OGTT is the 
gold standard but in the U.S it has almost entirely been 
replaced by the HbA1c due to the ease of testing.
Difficulties experienced in this study include not hav-
ing longitudinal access to the study subjects and variabil-
ity in the local resources. Due to inconsistent electricity, 
we lost a substantial number of glucose readings because 
centrifugation of the sample was inadequate and glycoly-
sis occurred in the sample vials. Despite the limitations, 
this study exposes some important differences that need 
further investigation in order to identify those adoles-
cents at greatest risk of chronic diseases. Additional stud-
ies to determine specific lifestyle factors that influence 
these risk factors are currently being conducted with 
adolescents in Ecuador. Future studies should continue 
this work to determine what physiologic or environmen-
tal features best predict progression to or prevention of 
diabetes. In the meantime strong consideration should be 
placed on using the HbA1c for screening for diabetes and 
prediabetes in LA adolescents.
Conclusions
In conclusion, this study found lower than anticipated 
rates of overweight and obesity as well as relatively low 
rates of biochemical metabolic abnormalities and meta-
bolic syndrome. Notably, 10% of the adolescents in 
the sample met the diagnostic criteria for prediabetes, 
despite low levels of dyslipidemia and hyperglycemia. 
Although rates of obesity in Ecuadorian adolescents are 
low there is significant evidence to suggest that predia-
betes is permeating the smaller urban centers. Perhaps 
of most concern, and worthy of future study, is the clear 
and substantive disparity in rates of prediabetes in ado-
lescents from the large urban center as compared to the 
smaller urban center. Use of HbA1c identified more ado-
lescents with prediabetes than FBG. The HbA1c measure 
is an attractive screening tool for prediabetes in develop-
ing countries. Traditional screening tools may underesti-
mate this risk.
This study builds upon important research describ-
ing the epidemiology of children and adolescents in 
developing countries in LA. Developing countries with 
public health systems that can recognize and respond 
to these health challenges in the adolescent population 
may be more able to slow the rise of many preventable 
chronic diseases such as diabetes. The non-communica-
ble chronic diseases such as diabetes, hypertension, and 
non-alcoholic fatty liver disease will become an increas-
ing burden for countries in transition if no action is taken 
to reduce the precursors of these diseases in children and 
adolescents.
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